摘要
我们根据聚乳酸薄膜在体内无毒、无致癌性,能自行降解的特性,将它包裹肌腱缝合口。通过动物实验观察,术后3～9周肌腱周围形成一个完整的腔隙,薄膜在体内13周开始出现降解吸收,至24周薄膜基本吸收,能达到预防粘连的目的。从1985年11月～1989年9月,临床应用14例20条肌腱。随访结果,优良率为81.8％。使用聚乳酸薄膜预防肌腱粘连的适应证为手指各区屈肌腱断裂作一期、延迟一期或二期缝合的病例。
The poly-lactic acid membrane is characterized by its non-toxicity, non-carcinogenic and the property of degradation in the body in animal experiment, this membrane was wrapped around the tenorrhaphy site. The results showed that 3 to 9 weeks after operation there was an intact space surrounding the tendon, and the membrane began to degradate at 24 weeks, might achieve the purpose to prevent the formation of adhesion. From Nov. 1985 to Sept. 1989, this membrane was applied to 20 tendons of 14 patients. The follow-up results showed that the satisfactory rate was 81.8%. the indications of using poly-lactic acid membrane were primary, delayed primary and secondary suture of flexor tendon injuries in all areas of the fingers.
出处
《中国修复重建外科杂志》
CAS
CSCD
1992年第2期65-67,共3页
Chinese Journal of Reparative and Reconstructive Surgery
关键词
聚乳酸薄膜
肌腱粘连
屈肌腱损伤
Poly-lactic acid membrane Adhesion of tendon Injury of flesor tendon
